Industry Seeks Flexibility, Clarity On US FDA Clinical Trial Diversity Action Plan Requirements

 
• By Sue Sutter
  
Flexibility ribbon
Industry wants FDA flexibility on setting enrollment goals for diversity action plans. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D